Stock listing
HNSAS Stock Price, News, Filings & Events — Hansa Biopharma Ab
Selected listing: HNSAS · AQUISEU · SEK · GB
This page tracks Hansa Biopharma Ab's HNSAS:AQUISEU listing on AQUISEU in SEK for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HNSAS:AQUISEU. HNSAS:AQUISEU is the stock-level entry point for investors researching Hansa Biopharma Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- HNSAS:AQUISEU
- Asset type
- Stock
- Market cap
- $470.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AQUISEU
- Currency
- SEK
Hansa Biopharma Ab HNSAS:AQUISEU stock context
This page tracks Hansa Biopharma Ab's HNSAS:AQUISEU listing on AQUISEU in SEK for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HNSAS:AQUISEU. HNSAS:AQUISEU is the stock-level entry point for investors researching Hansa Biopharma Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Hansa Biopharma Ab
Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA
July 1, 2026
Bulletin from the Annual General Meeting in Hansa Biopharma AB (publ)
June 1, 2026
Hansa Biopharma reports positive efficacy and safety results from Idefirix[®] European post authorization study in kidney transplantation
May 27, 2026
Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
May 25, 2026
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix from Hansa Biopharma for EUR115 million
May 20, 2026
Hansa Biopharma Ab earnings calls
Hansa Biopharma AB (publ) (HNSA) Q2 2026 Earnings Call
July 22, 2026 · Replay with transcript and chapters
Hansa Biopharma AB (publ) (HNSA) Q1 2026 Earnings Call
April 23, 2026 · Replay with transcript and chapters
Hansa Biopharma AB (publ) (HNSA) Q4 2025 Earnings Call
February 11, 2026 · Replay with transcript and chapters
Hansa Biopharma AB (publ) (HNSA) Q3 2025 Earnings Call
October 30, 2025 · Replay with transcript and chapters
Hansa Biopharma AB (publ) (HNSA) Q2 2025 Earnings Call
July 17, 2025 · Replay with transcript and chapters
Hansa Biopharma AB (publ) (HNSA) Q1 2025 Earnings Call
April 24, 2025 · Replay with transcript and chapters
Research Hansa Biopharma Ab
Hansa Biopharma Ab investor report
Review AI stock analysis and investor report context for HNSAS:AQUISEU.
Hansa Biopharma Ab company profile
View the public company page for Hansa Biopharma Ab on 6ix.
Hansa Biopharma Ab news
Read company news and market updates connected to Hansa Biopharma Ab.
Hansa Biopharma Ab investor events
Find investor webinars, events, and replay context for Hansa Biopharma Ab.
Alternate listings
HNSA:OMXSTO
SE · SEK
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
0RC7:LSIN
GB · SEK
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
24H:GETTEX
DE · EUR
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
A0M65T:LSX
DE · EUR
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
A0M65T:LS
DE · EUR
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
HNSBF:OTC
US · USD
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
HNSAS:AQUISUK
GB · SEK
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
24H:DUS
DE · EUR
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
24H:FWB
DE · EUR
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
24H:MUN
DE · EUR
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
24H:SWB
DE · EUR
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.
24H:TRADEGATE
DE · EUR
Alternate listing for Hansa Biopharma Ab; the primary context on this page is HNSAS:AQUISEU.